tiprankstipranks
CARsgen Therapeutics Holdings Ltd. (HK:2171)
:2171
Hong Kong Market
2171
CARsgen Therapeutics Holdings Ltd.
RESEARCH TOOLSreports

CARsgen Therapeutics Holdings Ltd. (2171) Income Statement

2 Followers

CARsgen Therapeutics Holdings Ltd. Income Statement

Last quarter (Q4 2025), CARsgen Therapeutics Holdings Ltd.'s total revenue was ¥73.45M, an increase of Infinity% from the same quarter last year. In Q4, CARsgen Therapeutics Holdings Ltd.'s net income was ¥-22.15M. See CARsgen Therapeutics Holdings Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
¥ 122.41M¥ 39.42M¥ 0.00¥ 0.00¥ 25.81M
Gross Profit
¥ 49.15M¥ 14.75M¥ -96.57M¥ -94.81M¥ 25.81M
Operating Expenses
¥ 278.30M¥ 822.94M¥ 767.65M¥ 881.30M¥ 599.72M
Depreciation and Amortization
¥ 28.73M¥ 65.14M¥ 67.41M¥ 56.92M¥ 52.45M
EBITDA
¥ -200.42M¥ -686.61M¥ -717.64M¥ -748.73M¥ -4.67B
Operating Income
¥ -229.15M¥ -808.19M¥ -767.65M¥ -881.30M¥ -573.90M
Other Income/Expenses
¥ 128.91M¥ 10.40M¥ 20.26M¥ -9.65M¥ -4.16B
Pretax Income
¥ -100.24M¥ -797.79M¥ -747.39M¥ -890.95M¥ -4.74B
Net Income
¥ -95.33M¥ -798.13M¥ -747.79M¥ -892.25M¥ -4.74B
Per Share Metrics
Basic EPS
¥ -0.17¥ -1.44¥ -1.34¥ -1.62¥ -12.26
Diluted EPS
¥ -0.17¥ -1.44¥ -1.34¥ -1.62¥ -12.26
Weighted Average Shares Outstanding
 552.06M 552.88M 556.13M 551.63M 549.89M
Weighted Average Shares Outstanding (Diluted)
 552.06M 552.88M 556.13M 551.63M 549.89M
Currency in CNY

CARsgen Therapeutics Holdings Ltd. Earnings and Revenue History